borderline significantP = 0.049
ERAS was associated with a borderline significant reduction in 30-day mortality (RR = 0.53, 95% CI: 0.28–1.00, P = 0.049; Figure 6 ).
ERAS was associated with a borderline significant reduction in 30-day mortality (RR = 0.53, 95% CI: 0.28–1.00, P = 0.049; Figure 6 ).